Immunometabolic disorders in type 2 diabetes mellitus mediated by NLRP3 inflammasome activation and methods of pharmacological correction thereof

N. I. Cheplyaeva; Д. A. Babkov; A. V. Lukyanov; R. D. Danilov; A. A. Spasov

doi:10.14341/probl13590-10938

For citations:

Cheplyaeva N.I., Babkov Д.A., Lukyanov A.V., Danilov R.D., Spasov A.A. Immunometabolic disorders in type 2 diabetes mellitus mediated by NLRP3 inflammasome activation and methods of pharmacological correction thereof. Problems of Endocrinology. 2025;71(6):76-86. (In Russ.) https://doi.org/10.14341/probl13590

Views PDF (Rus): 13

JATS XML

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Problems of Endocrinology

For citations:

Cookies policy